Date: Mon, 08 Jun 2020 09:49:15 +0100
Subject: access to documents request - Work with Palantir
From: Mathias Schindler <xxxxxxxxxxxxxxxxxxxxxxxxx@xxxxxxxx.xxx>
To: documents requests at EMA <xxxx@xxx.xxxxxx.xx>

Dear European Medicines Agency,

Palantir Technologies, Inc. is a private company supplying products and services.

I am asking for any information related to palantir and its products and services, including

a) meeting records (drafts, memos, invitations, appointments, cancellations) involving Palantir officials and people representing Palantir and their interests

b) correspondence (including within the [Authority name] and with the European institutions concerning Palantir technologies and / or its products and services or the regulatory environment of the EU that affects their products and services. This may include policy papers, consultation input, memoranda or any other form of information.

c) invoices, tenders, service agreements, purchases, orders, procurement documents, offers etc. concerning products and services using Palantir Technologies.

Please do not transfer this request to another Autority, this is a request specifically for you. Do not exclude short-lived documents or documents considered to be unimportant under archiving rules.

Please ensure that information that is considered to be excempt for access for this request is not automatically deleted within to make sure that subsequent confirmatory applications and legal appeals as well as Ombudsman office inquiries can still access and assess them.

Yours faithfully,

Mathias Schindler

-------------------------------------------------------------------

This is a request for access to information under Article 15 of the TFEU and, where applicable, Regulation 1049/2001 which has been sent via the AsktheEU.org website.

Please kindly use this email address for all replies to this request: xxxxxxxxxxxxxxxxxxxxxxxxx@xxxxxxxx.xxx

If xxxx@xxx.xxxxxx.xx is the wrong address for information requests to European Medicines Agency, please tell the AsktheEU.org team on email xxxx@xxxxxxxx.xxx

This message and all replies from European Medicines Agency will be published on the AsktheEU.org website. For more information see our dedicated page for EU public officials at https://www.asktheeu.org/en/help/officers

Please note that in some cases publication of requests and responses will be delayed.


-------------------------------------------------------------------